Drugs / SZ011
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05686720 | Feb 2023 → Feb 2024 | triple-negative breast carcinoma | First Affiliated Hospital of Shantou University Medical College | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SZ011 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05686720 ↗ |
| Modality | Cell therapy | “SZ011 CAR-NK” NCT05686720 ↗ |